WASHINGTON - Concern over possible contamination has caused a manufacturer to recall some eye ointment products distributed nationwide to wholesalers, retailers, and via the product distributor, Walmart, CVS, and AACE Pharmaceuticals Inc.

The products are being recalled due to a lack of sterility assurance noted during an inspection conducted by the Food and Drug Administration.

The FDA says patients using these products risk potential risk of eye infections or related harm.

The recalled ophthalmic products, which are supposed to be sterile, pose a potentially heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses.

As of Wednesday, manufacturer Brassica Pharma Pvt. Ltd. announced that it has not received any reports of adverse events up to 16th February 2024 related to the recall.

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Products listed in the table below with expiration dates ranging from February 2024 to September 2025 are included in the recall:

 Brassica Pharma Pvt. Ltd. Is notifying its distributors AACE Pharmaceuticals Inc. and its retailers Walmart and CVS.

Consumers should stop using the recalled eye ointment and may return the listed products to the place of purchase.

Those with questions regarding this recall can contact Brassica Pharma Pvt. Ltd. at +1 833-225-9564 or info@brassicapharma.com.